These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 714310)

  • 1. Mode of antagonism of vitamin K by anticoagulants.
    Nutr Rev; 1978 Sep; 36(9):289-91. PubMed ID: 714310
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.
    Willingham AK; Laliberte RE; Bell RG; Matschiner JT
    Biochem Pharmacol; 1976 May; 25(9):1063-6. PubMed ID: 1267851
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of coumarins. Significance of vitamin K epoxide.
    Sadowski JA; Suttie JW
    Biochemistry; 1974 Aug; 13(18):3696-9. PubMed ID: 4853124
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
    Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
    Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
    Pearson DA
    Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants.
    Hodroge A; Longin-Sauvageon C; Fourel I; Benoit E; Lattard V
    Arch Biochem Biophys; 2011 Nov; 515(1-2):14-20. PubMed ID: 21907178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of the antagonism between vitamin K and coumarin antiboagulants.
    Lowenthal J; MacFarlane JA
    Thromb Diath Haemorrh; 1968 Jul; 19(3):611. PubMed ID: 5708143
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetics of vitamin K antagonists.
    Gage BF; Eby CS
    Pharmacogenomics J; 2004; 4(4):224-5. PubMed ID: 15148502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
    Thonnart N; Letist D; Reuse J
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin K antagonists: the first 50 years.
    Griminger P
    J Nutr; 1987 Jul; 117(7):1325-9. PubMed ID: 3302140
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of oral anticoagulants].
    Richter M; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):8-17. PubMed ID: 433362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?
    Zaragatski E; Grommes J; Schurgers LJ; Langer S; Kennes L; Tamm M; Koeppel TA; Kranz J; Hackhofer T; Arakelyan K; Jacobs MJ; Kokozidou M
    Kidney Int; 2016 Mar; 89(3):601-11. PubMed ID: 26466318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.